Latigo Biotherapeutics, Inc. (LTGO)

NASDAQ: LTGO · Real-Time Price · USD

21.77

-0.49 (-2.20%)

Sep 2, 2026, 4:00 PM EDT - Market closed

Latigo Biotherapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Sep '26 Sep 2, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Market Capitalization	1,377	-	-
Market Cap Growth	-	-	-
Enterprise Value	1,335	-	-

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Sep '26 Sep 2, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Debt / Equity Ratio	0.02	0.01	0.11
Net Debt / Equity Ratio	-1.16	-1.21	-2.15
Net Debt / EBITDA Ratio	0.37	0.62	0.27
Net Debt / FCF Ratio	0.40	0.70	0.33
Quick Ratio	2.91	3.76	1.24
Current Ratio	3.23	4.00	1.47
Return on Equity (ROE)	-	-336.74%	-
Return on Assets (ROA)	-	-140.26%	-
Return on Capital Employed (ROCE)	-311.20%	-193.40%	-752.80%

Yields

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Sep '26 Sep 2, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Buyback Yield / Dilution	-	-24.39%	-

SEC Filings: 10-K · 10-Q